-
Something wrong with this record ?
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines
J. Stangl-Kremser, L. Lambertini, F. Di Maida, A. Martinez-Fundichely, M. Ferro, B. Pradere, F. Soria, S. Albisinni, Z. Wu, F. Del Giudice, GE. Cacciamani, M. Valerio, A. Briganti, M. Rouprêt, SF. Shariat, C. Lee, A. Minervini, M. Moschini, A....
Language English Country Netherlands
Document type Journal Article, Review
- MeSH
- Humans MeSH
- Urinary Bladder Neoplasms * surgery MeSH
- Enhanced Recovery After Surgery * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Radical cystectomy with pelvic lymphadenectomy and urinary diversion is the standard treatment for patients diagnosed with localized muscle-invasive bladder cancer. Enhanced recovery after surgery (ERAS) is a multimodal perioperative care pathway comprising recommendations on different items with variable evidence that are aimed at improving outcomes. This review provides an overview of the application of specific elements of the ERAS guidelines. Forty-eight series were identified through our literature search. The studies reported a median of 16 out of the 22 ERAS steps (72.7%). The elements were applied in 79.3% of cases (interquartile range 61.1-85%) if mentioned in the studies, decreasing to 73.5% in the postoperative period. PATIENT SUMMARY: Guidelines on enhanced recovery after surgery recommend steps to follow and cover all areas of the patient's journey through the surgical process. We looked at the application of the elements for patients with bladder cancer. We found inconsistent reporting and use.
Department of Physiology and Biophysics Weill Cornell Medicine New York NY 10065 USA
Department of Urology 2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Urology Changhai Hospital Naval Medical University Shanghai China
Department of Urology Institut Jules Bordet Université Libre de Bruxelles Brussels Belgium
Department of Urology The Ohio State University Columbus OH USA
Department of Urology University Hospital of Lausanne Switzerland
Department of Urology University of Texas Southwestern Dallas TX USA
Department of Urology University of Vienna Vienna Austria
Division of Urology European Institute of Oncology Milan Italy
European Association of Urology Research Foundation Arnhem The Netherlands
Institute for Computational Biomedicine Weill Cornell Medicine New York NY 10021 USA
Karl Landsteiner Institute of Urology and Andrology Vienna Austria
Meyer Cancer Center Weill Cornell Medicine New York NY 10065 USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032918
- 003
- CZ-PrNML
- 005
- 20230131151849.0
- 007
- ta
- 008
- 230120s2022 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.euf.2022.06.004 $2 doi
- 035 __
- $a (PubMed)35773181
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Stangl-Kremser, Judith $u Department of Urology, University of Vienna, Vienna, Austria
- 245 10
- $a Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines / $c J. Stangl-Kremser, L. Lambertini, F. Di Maida, A. Martinez-Fundichely, M. Ferro, B. Pradere, F. Soria, S. Albisinni, Z. Wu, F. Del Giudice, GE. Cacciamani, M. Valerio, A. Briganti, M. Rouprêt, SF. Shariat, C. Lee, A. Minervini, M. Moschini, A. Mari, European Association of Urology-Young Academic Urologists Urothelial Carcinoma Working Group
- 520 9_
- $a Radical cystectomy with pelvic lymphadenectomy and urinary diversion is the standard treatment for patients diagnosed with localized muscle-invasive bladder cancer. Enhanced recovery after surgery (ERAS) is a multimodal perioperative care pathway comprising recommendations on different items with variable evidence that are aimed at improving outcomes. This review provides an overview of the application of specific elements of the ERAS guidelines. Forty-eight series were identified through our literature search. The studies reported a median of 16 out of the 22 ERAS steps (72.7%). The elements were applied in 79.3% of cases (interquartile range 61.1-85%) if mentioned in the studies, decreasing to 73.5% in the postoperative period. PATIENT SUMMARY: Guidelines on enhanced recovery after surgery recommend steps to follow and cover all areas of the patient's journey through the surgical process. We looked at the application of the elements for patients with bladder cancer. We found inconsistent reporting and use.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a urychlená pooperační rehabilitace $7 D000080482
- 650 12
- $a nádory močového měchýře $x chirurgie $7 D001749
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Lambertini, Luca $u Oncologic Minimally Invasive Urology and Andrology Unit, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy
- 700 1_
- $a Di Maida, Fabrizio $u Oncologic Minimally Invasive Urology and Andrology Unit, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy
- 700 1_
- $a Martinez-Fundichely, Alexander $u Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10065, USA; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10021, USA; Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA
- 700 1_
- $a Ferro, Matteo $u Division of Urology, European Institute of Oncology, Milan, Italy
- 700 1_
- $a Pradere, Benjamin $u Department of Urology, University of Vienna, Vienna, Austria
- 700 1_
- $a Soria, Francesco $u Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy
- 700 1_
- $a Albisinni, Simone $u Department of Urology, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Department of Urology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
- 700 1_
- $a Wu, Zhenjie $u Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China
- 700 1_
- $a Del Giudice, Francesco $u Department of Maternal-Infant and Urological Sciences, Sapienza, Rome University, Policlinico Umberto I Hospital, Rome, Italy
- 700 1_
- $a Cacciamani, Giovanni E $u USC Institute of Urology and Catherine & Joseph Aresty, Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
- 700 1_
- $a Valerio, Massimo $u Department of Urology, University Hospital of Lausanne, Switzerland
- 700 1_
- $a Briganti, Alberto $u Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 700 1_
- $a Rouprêt, Morgan $u Urology, Predictive Onco-Urology, AP-HP, Urology Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France
- 700 1_
- $a Shariat, Shahrokh F $u Department of Urology, University of Vienna, Vienna, Austria; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10065, USA; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; European Association of Urology Research Foundation, Arnhem, The Netherlands
- 700 1_
- $a Lee, Cheryl $u Department of Urology, The Ohio State University, Columbus, OH, USA
- 700 1_
- $a Minervini, Andrea $u Oncologic Minimally Invasive Urology and Andrology Unit, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy
- 700 1_
- $a Moschini, Marco $u Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 700 1_
- $a Mari, Andrea $u Oncologic Minimally Invasive Urology and Andrology Unit, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy. Electronic address: andrea.mari@unifi.it
- 710 2_
- $a European Association of Urology-Young Academic Urologists Urothelial Carcinoma Working Group
- 773 0_
- $w MED00193513 $t European urology focus $x 2405-4569 $g Roč. 8, č. 6 (2022), s. 1622-1626
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35773181 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151844 $b ABA008
- 999 __
- $a ok $b bmc $g 1891588 $s 1184253
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 8 $c 6 $d 1622-1626 $e 20220627 $i 2405-4569 $m European urology focus $n Eur Urol Focus $x MED00193513
- LZP __
- $a Pubmed-20230120
